(Q33488092)
Statements
Mitomycin-ifosfamide-cisplatinum (MIP) vs MIP-interferon vs cisplatinum-carboplatin in metastatic non-small-cell lung cancer: a FONICAP randomised phase II study. Italian Lung Cancer Task Force (English)
A Ardizzoni
G F Addamo
E Baldini
U Borghini
L Portalone
F De Marinis
R Lionetto
1 reference
1 reference
1 reference
1 reference